Defiance Autism Impact ETF (ASD)
| Assets | $1.35M |
| Expense Ratio | 0.79% |
| PE Ratio | 15.02 |
| Shares Out | 50,000 |
| Dividend (ttm) | $0.01 |
| Dividend Yield | 0.02% |
| Ex-Dividend Date | Jun 24, 2026 |
| Payout Frequency | n/a |
| Payout Ratio | 0.34% |
| Volume | 59 |
| Open | 27.04 |
| Previous Close | 26.95 |
| Day's Range | 27.04 - 27.04 |
| 52-Week Low | 24.59 |
| 52-Week High | 28.52 |
| Beta | n/a |
| Holdings | 41 |
| Inception Date | Jun 1, 2026 |
About ASD
Fund Home PageThe Defiance Autism Impact ETF (ASD) is an exchange-traded fund that is based on the VettaFi Autism Impact index. The fund tracks an equal-weighted index of companies from developed markets supporting individuals on the autism spectrum and broader community. The fund donates profits to organizations focused on autism care, research, and access to resources. ASD was launched on Jun 1, 2026 and is issued by Defiance.
Top 10 Holdings
32.86% of assets| Name | Symbol | Weight |
|---|---|---|
| Definium Therapeutics, Inc. | DFTX | 4.28% |
| Neuren Pharmaceuticals Limited | NEU | 3.83% |
| LifeStance Health Group, Inc. | LFST | 3.37% |
| ACADIA Pharmaceuticals Inc. | ACAD | 3.27% |
| Otsuka Holdings Co., Ltd. | 4578 | 3.27% |
| Repligen Corporation | RGEN | 3.22% |
| Revvity, Inc. | RVTY | 3.02% |
| Anavex Life Sciences Corp. | AVXL | 2.95% |
| Acadia Healthcare Company, Inc. | ACHC | 2.86% |
| Life Healthcare Group Holdings Limited | LHC | 2.78% |
Performance
News
How to Invest in the Growing Autism Care Economy
The autism care economy is expanding across healthcare, technology, education, and behavioral services. As a result, investors are beginning to look at the companies serving it through a broader inves...
How Autism Research ETF ASD Can Deliver for Your Portfolio
ETFs allow investors a plethora of ways to express themselves while also pursuing performance. With each passing year, new ETFs arrive to help investors meet their personal and financial goals.
MapLight Announces Topline Results from Phase 2 IRIS Study for ML-004 in Autism Spectrum Disorder
SAN FRANCISCO and BOSTON, June 22, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (Nasdaq: MPLT), a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering ...
Defiance Launches the First Autism-Impact ETF (Ticker: ASD), Donating Profits to Autism Causes *
MIAMI, June 02, 2026 (GLOBE NEWSWIRE) -- Defiance ETFs today announced the launch of the Defiance Autism Impact ETF (Ticker: ASD) , the first exchange-traded fund designed to provide targeted exposure...